Evidence map›Paper›PMID 35962744›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.

Eva Pescosolido, Yannick D Muller, Marina Sabaté-Brescó, Marta Ferrer, Daniel Yerly, Jean-Christoph Caubet, Jean-Pierre Lantin, Camillo Ribi, Marcel M Bergmann

Abstract readLetter
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. New-onset chronic spontaneous urticaria post-COVID-19 vaccination-South African case series.The journal of allergy and clinical immunology. Global · 2023
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eva PescosolidoCentro Pediatrico del Mendrisiotto, Mendrisio, Switzerland.
Yannick D MullerService d'Immunologie et Allergie, CHUV, Lausanne, Switzerland.ORCID 0000-0003-0513-7156
Marina Sabaté-BrescóAllergy Department, Clínica Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain.ORCID 0000-0003-2200-0485
Marta FerrerAllergy Department, Clínica Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain.ORCID 0000-0001-8495-1302
Daniel YerlyAdverse Drug Reactions - Analysis and Consulting, Bern, Switzerland.
Jean-Christoph CaubetPediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland.
Jean-Pierre LantinClinica Luganese Moncucco, Lugano, Switzerland.
Camillo RibiService d'Immunologie et Allergie, CHUV, Lausanne, Switzerland.
Marcel M BergmannCentro Pediatrico del Mendrisiotto, Mendrisio, Switzerland.ORCID 0000-0002-1905-5162

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic UrticariaCOVID-19Antibodies, ViralCOVID-19 VaccinesHumansRNA, MessengerSARS-CoV-2Antibodies, ViralCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID35962744
PMCPMC9539124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.